                               SEQUENCE LISTING

<110> FRITSCH, EDWARD 
 
<120> MULTI-DOMAIN PROTEIN VACCINE

<130> DFS-40025

<140> PCT/US2020/054785
<141> 2020-10-08

<150> 62/912,903
<151> 2019-10-09

<160> 16    

<170> PatentIn version 3.5

<210> 1
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Gly Gly Gly Gly Ser 
1               5   


<210> 2
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Lys Glu Ser Gly Ser Val Ser Ser Glu Gln Leu Ala Gln Phe Arg Ser 
1               5                   10                  15      


Leu Asp 
        


<210> 3
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Glu Gly Lys Ser Ser Gly Ser Gly Ser Glu Ser Lys Ser Thr 
1               5                   10                  


<210> 4
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(10)
<223> This sequence may encompass 5-10 residues

<400> 4
Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
1               5                   10  


<210> 5
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Gly Gly Gly Gly Gly Gly Gly Gly 
1               5               


<210> 6
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Gly Ser Ala Gly Ser Ala Ala Gly Ser Gly Glu Phe 
1               5                   10          


<210> 7
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Glu Ala Ala Ala Lys 
1               5   


<210> 8
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6xHis tag

<400> 8
His His His His His His 
1               5       


<210> 9
<211> 28
<212> PRT
<213> Mus sp.

<400> 9
Gly Ile Pro Val His Leu Glu Leu Ala Ser Met Thr Asn Met Glu Leu 
1               5                   10                  15      


Met Ser Ser Ile Val His Gln Gln Val Phe Pro Thr 
            20                  25              


<210> 10
<211> 28
<212> PRT
<213> Mus sp.

<400> 10
Gly Arg Val Leu Glu Leu Phe Arg Ala Ala Gln Leu Ala Asn Asp Val 
1               5                   10                  15      


Val Leu Gln Ile Met Glu Leu Cys Gly Ala Thr Arg 
            20                  25              


<210> 11
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Trp Ala Leu Trp Leu Asp Asp Ser Tyr Trp Thr Pro Tyr Met 
1               5                   10                  


<210> 12
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Met Ala Tyr Met Ile Cys Gln Leu Phe His Met Asp Phe Trp Leu Leu 
1               5                   10                  15      


Ile Ile 
        


<210> 13
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Thr Trp Thr Glu Phe Asp Glu Pro Phe Leu Ile Arg Asn Val Gln Ser 
1               5                   10                  15      


Val Ser Ile 
            


<210> 14
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Ser Glu Glu Leu Asn Ile Phe Ile Arg Cys Phe Lys Asp Phe Gln Leu 
1               5                   10                  15      


Gln Arg Ala Asn Lys 
            20      


<210> 15
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Leu Glu Tyr Val Ala Phe Ser Gln Arg Phe Ile Pro Glu Leu 
1               5                   10                  


<210> 16
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Thr Pro Tyr Leu Lys Glu Thr Leu Asn Phe Ile Trp Asn Val Glu Asp 
1               5                   10                  15      


His Ile Asn Pro Lys 
            20      


